LINC00271, long intergenic non-protein coding RNA 271, 100131814
N. diseases: 20; N. variants: 12
Source: ALL
Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
C | 0.800 | GeneticVariation | GWASCAT | Common genetic variants associate with serum phosphorus concentration. | 20558539 | 2010 | ||||||
|
|
|
C | 0.800 | GeneticVariation | GWASDB | Common genetic variants associate with serum phosphorus concentration. | 20558539 | 2010 | ||||||
|
|
|
C | 0.800 | GeneticVariation | GWASCAT | Common genetic variants associate with serum phosphorus concentration. | 20558539 | 2010 | ||||||
|
|
|
C | 0.800 | GeneticVariation | GWASDB | Common genetic variants associate with serum phosphorus concentration. | 20558539 | 2010 | ||||||
|
|
|
0.710 | GeneticVariation | BEFREE | Data from large samples of Danish individuals do not support a role for AHI1 rs1535435 nor rs9494266 as major type 2 diabetes variants. | 18227995 | 2008 | |||||||
|
|
|
0.710 | GeneticVariation | GWASDB | Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. | 17668382 | 2007 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | Leveraging Polygenic Functional Enrichment to Improve GWAS Power. | 30595370 | 2019 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | Leveraging Polygenic Functional Enrichment to Improve GWAS Power. | 30595370 | 2019 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | Leveraging Polygenic Functional Enrichment to Improve GWAS Power. | 30595370 | 2019 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | Leveraging Polygenic Functional Enrichment to Improve GWAS Power. | 30595370 | 2019 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | Leveraging Polygenic Functional Enrichment to Improve GWAS Power. | 30595370 | 2019 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | Leveraging Polygenic Functional Enrichment to Improve GWAS Power. | 30595370 | 2019 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | Leveraging Polygenic Functional Enrichment to Improve GWAS Power. | 30595370 | 2019 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | Leveraging Polygenic Functional Enrichment to Improve GWAS Power. | 30595370 | 2019 | |||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | Leveraging Polygenic Functional Enrichment to Improve GWAS Power. | 30595370 | 2019 | |||||||
|
|
|
T | 0.700 | GeneticVariation | GWASCAT | Genome-wide association study of Alzheimer's disease endophenotypes at prediagnosis stages. | 29274321 | 2018 | ||||||
|
|
|
A | 0.700 | GeneticVariation | GWASCAT | Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients. | 22610502 | 2012 | ||||||
|
|
|
0.010 | GeneticVariation | BEFREE | The case-control analysis did not show any difference in the genotypic distribution of the SNPs, while in the allelic analysis, a weak association was found between the rs9647635 A allele and SCZ. | 25622261 | 2015 | |||||||
|
|
|
0.010 | GeneticVariation | BEFREE | Particularly, rs7750586 and rs911507, both located upstream of the AHI1 coding region, were found to be associated with schizophrenia in the analysis of genotypic (p = 0.0033, and 0.031, respectively) and allelic frequencies (p = 0.001 in both cases). | 20805890 | 2010 | |||||||
|
|
|
0.010 | GeneticVariation | BEFREE | Particularly, rs7750586 and rs911507, both located upstream of the AHI1 coding region, were found to be associated with schizophrenia in the analysis of genotypic (p = 0.0033, and 0.031, respectively) and allelic frequencies (p = 0.001 in both cases). | 20805890 | 2010 |